Intercontinental Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Intercontinental Wealth Advisors's GILD Position: Q2 2023 in Review
Intercontinental Wealth Advisors increased its Gilead Sciences (GILD) stake by 2.4% in Q2 2023, buying an estimated $10K and bringing the position to 5,458 shares worth $421K. The position accounts for 0.1% of the portfolio, ranked #209.
Intercontinental Wealth Advisors first reported a position in GILD in Q4 2016 and has held it in 24 quarters since. The position peaked at $668K in Q4 2021. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.
- Intercontinental Wealth Advisors held 5,458 shares of Gilead Sciences worth $421K as of Q2 2023.
- Intercontinental Wealth Advisors bought 126 Gilead Sciences shares in Q2 2023, an estimated $10K.
- Gilead Sciences made up 0.1% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #209 holding.
- Intercontinental Wealth Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 24 quarters since.
- Intercontinental Wealth Advisors's Gilead Sciences position peaked at $668K in Q4 2021.
- 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.
Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.